Skip to content

Dr Andrew McLean

Non-Executive Director

Andy is the lead life sciences investor at Oxford Sciences Innovation plc overseeing a portfolio of 11 life sciences companies. In this role, he was also involved in seeding Evox Therapeutics, Vaccitech, and Lab282. Before joining OSI he was a consultant in McKinsey & Company’s London office. He trained as a Doctor at the University of Western Australian before taking a degree in philosophy, politics & economics at Christ Church, University of Oxford.

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.